The Pennant Group, Inc. (PNTG)
USD 28.15
(-3.63%)
USD 28.15
(-3.63%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 30.36 Million USD | 24.97% |
| 2022 | 24.6 Million USD | 159.89% |
| 2021 | 9.45 Million USD | -60.3% |
| 2020 | 23.81 Million USD | 151.23% |
| 2019 | 9.48 Million USD | -59.82% |
| 2018 | 23.59 Million USD | 31.48% |
| 2017 | 17.94 Million USD | 13.32% |
| 2016 | 15.83 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 11.42 Million USD | 21.21% |
| 2024 Q1 | 8.6 Million USD | 1.72% |
| 2023 Q1 | 5.59 Million USD | -29.04% |
| 2023 FY | - USD | 24.97% |
| 2023 Q2 | 7.51 Million USD | 34.4% |
| 2023 Q3 | 8.34 Million USD | 11.11% |
| 2023 Q4 | 8.65 Million USD | 3.64% |
| 2022 Q4 | 7.87 Million USD | -6.01% |
| 2022 FY | - USD | 159.89% |
| 2022 Q3 | 8.38 Million USD | 76.61% |
| 2022 Q2 | 4.74 Million USD | 36.54% |
| 2022 Q1 | 3.47 Million USD | 465.89% |
| 2021 Q2 | 4.71 Million USD | 69.12% |
| 2021 Q1 | 2.78 Million USD | -47.72% |
| 2021 FY | - USD | -60.3% |
| 2021 Q3 | 2.9 Million USD | -38.45% |
| 2021 Q4 | -950 Thousand USD | -132.74% |
| 2020 Q2 | 7.27 Million USD | 37.46% |
| 2020 FY | - USD | 151.23% |
| 2020 Q4 | 5.33 Million USD | -9.84% |
| 2020 Q3 | 5.91 Million USD | -18.71% |
| 2020 Q1 | 5.29 Million USD | 1336.68% |
| 2019 Q2 | 4.27 Million USD | 62.08% |
| 2019 FY | - USD | -59.82% |
| 2019 Q3 | 2.99 Million USD | -29.88% |
| 2019 Q1 | 2.63 Million USD | -52.08% |
| 2019 Q4 | -428 Thousand USD | -114.28% |
| 2018 Q2 | 6.27 Million USD | 18.9% |
| 2018 Q3 | 6.54 Million USD | 4.35% |
| 2018 FY | - USD | 31.48% |
| 2018 Q1 | 5.27 Million USD | 0.0% |
| 2018 Q4 | 5.5 Million USD | -15.92% |
| 2017 FY | - USD | 13.32% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | 83.941% |
| Addus HomeCare Corporation | 106.55 Million USD | 71.5% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | -7.265% |
| Amedisys, Inc. | 216.91 Million USD | 85.999% |
| American Oncology Network, Inc. | -39.35 Million USD | 177.175% |
| Astrana Health, Inc. | 123.68 Million USD | 75.447% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | 31.521% |
| IMAC Holdings, Inc. | -5.94 Million USD | 610.678% |
| biote Corp. | 9.23 Million USD | -228.882% |
| Cryo-Cell International, Inc. | -10.41 Million USD | 391.525% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | 76.519% |
| COMPASS Pathways plc | -123.8 Million USD | 124.53% |
| DocGo Inc. | 32.72 Million USD | 7.2% |
| The Ensign Group, Inc. | 353.23 Million USD | 91.403% |
| Healthcare Services Group, Inc. | 75.21 Million USD | 59.622% |
| InnovAge Holding Corp. | 1.15 Million USD | -2531.629% |
| Assure Holdings Corp. | -19.82 Million USD | 253.193% |
| The Joint Corp. | 9.14 Million USD | -232.202% |
| LifeStance Health Group, Inc. | -104.92 Million USD | 128.943% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | 295.24% |
| ModivCare Inc. | -26.75 Million USD | 213.529% |
| NewGenIvf Group Limited | 384.3 Thousand USD | -7802.317% |
| Novo Integrated Sciences, Inc. | -5.84 Million USD | 619.217% |
| Option Care Health, Inc. | 376.79 Million USD | 91.94% |
| P3 Health Partners Inc. | -81.07 Million USD | 137.46% |
| P3 Health Partners Inc. | -81.07 Million USD | 137.46% |
| Surgery Partners, Inc. | 446.1 Million USD | 93.192% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | 1170.882% |
| Talkspace, Inc. | -22.01 Million USD | 237.959% |
| Talkspace, Inc. | -22.01 Million USD | 237.959% |
| The Oncology Institute, Inc. | -70.45 Million USD | 143.105% |
| The Oncology Institute, Inc. | -70.45 Million USD | 143.105% |